Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8981275 | 0.97 | AGTR1 (0.43) | AGTR1AGTR2 | |
| SCHEMBL8980980 | 0.93 | AGTR1 (0.44) | AGTR1AGTR2 | |
| SCHEMBL8980937 | 0.93 | AGTR1 (0.37) | AGTR1AGTR2 | |
| SCHEMBL8980994 | 0.92 | AGTR1 (0.39) | AGTR1AGTR2 | |
| SCHEMBL8980740 | 0.92 | AGTR1 (0.37) | AGTR1AGTR2 | |
| SCHEMBL8980600 | 0.92 | AGTR1 (0.37) | AGTR1AGTR2 | |
| SCHEMBL8980896 | 0.89 | AGTR1 (0.35) | AGTR1AGTR2 | |
| SCHEMBL8980775 | 0.87 | AGTR1 (0.35) | AGTR1AGTR2 | |
| SCHEMBL8980694 | 0.87 | AGTR1 (0.35) | AGTR1AGTR2 | |
| SCHEMBL8981296 | 0.87 | AGTR1 (0.34) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5175180-A | Antagonist, antagonism | G. D. SEARLE & CO. (US) | 1992-12-29 | — | — | US | claimed |
| WO-1992011255-A1 | N-SUBSTITUTED N-(α-TRIAZOLYL-TOLUYL)PYRROLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1992-07-09 | — | — | WO | claimed |
| US-5484937-A | ANGIOTENSIN ANTAGONISTS | G.D. SEARLE & CO. (US) | 1996-01-16 | — | — | US | disclosed |
| US-5175180-A | Antagonist, antagonism | G. D. SEARLE & CO. (US) | 1992-12-29 | — | — | US | disclosed |
| WO-1992011255-A1 | N-SUBSTITUTED N-(α-TRIAZOLYL-TOLUYL)PYRROLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1992-07-09 | — | — | WO | disclosed |